Doron Pinhas Birger

S.D. Sight Diagnostics Ltd. develops medical devices for diagnosing blood diseases. Its product, the Parasight platform, is the automated microscopy device for Malaria diagnosis. The company was founded by Joseph Joel Pollak in 2011 and is headquartered in Tel Aviv, Israel.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

Galooli Ltd. specializes in remote monitoring and management for optimizing energy usage. The company is based in Tel Aviv, Israel. The Israeli company's industrial IoT software provides visibility and insights to create value. The company also introduces and optimizes renewable energy technologies for facilities to reduce carbon footprint and fuel reliance. Galooli helps organizations improve efficiency and comply with standards for utilities management. The company was founded by Ronen Barel, Itamar Molchadsky, and Ronen Barel has been the CEO since incorporation.

Galooli Ltd. specializes in remote monitoring and management for optimizing energy usage. The company is based in Tel Aviv, Israel. The Israeli company's industrial IoT software provides visibility and insights to create value. The company also introduces and optimizes renewable energy technologies for facilities to reduce carbon footprint and fuel reliance. Galooli helps organizations improve efficiency and comply with standards for utilities management. The company was founded by Ronen Barel, Itamar Molchadsky, and Ronen Barel has been the CEO since incorporation.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

D.V.I. - Dental Volunteers For Israel is a non-profit organization engaging in the provision of free dental care to indigent children in Jerusalem. The organization was founded by Trudi Birger in 1980 and is headquartered in Jerusalem, Israel.

S.D. Sight Diagnostics Ltd. develops medical devices for diagnosing blood diseases. Its product, the Parasight platform, is the automated microscopy device for Malaria diagnosis. The company was founded by Joseph Joel Pollak in 2011 and is headquartered in Tel Aviv, Israel.

S.D. Sight Diagnostics Ltd. develops medical devices for diagnosing blood diseases. Its product, the Parasight platform, is the automated microscopy device for Malaria diagnosis. The company was founded by Joseph Joel Pollak in 2011 and is headquartered in Tel Aviv, Israel.

S.D. Sight Diagnostics Ltd. develops medical devices for diagnosing blood diseases. Its product, the Parasight platform, is the automated microscopy device for Malaria diagnosis. The company was founded by Joseph Joel Pollak in 2011 and is headquartered in Tel Aviv, Israel.

S.D. Sight Diagnostics Ltd. develops medical devices for diagnosing blood diseases. Its product, the Parasight platform, is the automated microscopy device for Malaria diagnosis. The company was founded by Joseph Joel Pollak in 2011 and is headquartered in Tel Aviv, Israel.

S.D. Sight Diagnostics Ltd. develops medical devices for diagnosing blood diseases. Its product, the Parasight platform, is the automated microscopy device for Malaria diagnosis. The company was founded by Joseph Joel Pollak in 2011 and is headquartered in Tel Aviv, Israel.

S.D. Sight Diagnostics Ltd. develops medical devices for diagnosing blood diseases. Its product, the Parasight platform, is the automated microscopy device for Malaria diagnosis. The company was founded by Joseph Joel Pollak in 2011 and is headquartered in Tel Aviv, Israel.

S.D. Sight Diagnostics Ltd. develops medical devices for diagnosing blood diseases. Its product, the Parasight platform, is the automated microscopy device for Malaria diagnosis. The company was founded by Joseph Joel Pollak in 2011 and is headquartered in Tel Aviv, Israel.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

Part of University of Haifa, Carmel-Haifa University Economic Corp. Ltd. operates a university of commercialization and business. The company is based in Haifa, Israel. Elka Nir has been the CEO of the Israeli company since 2013.

Part of University of Haifa, Carmel-Haifa University Economic Corp. Ltd. operates a university of commercialization and business. The company is based in Haifa, Israel. Elka Nir has been the CEO of the Israeli company since 2013.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

S.D. Sight Diagnostics Ltd. develops medical devices for diagnosing blood diseases. Its product, the Parasight platform, is the automated microscopy device for Malaria diagnosis. The company was founded by Joseph Joel Pollak in 2011 and is headquartered in Tel Aviv, Israel.

Part of University of Haifa, Carmel-Haifa University Economic Corp. Ltd. operates a university of commercialization and business. The company is based in Haifa, Israel. Elka Nir has been the CEO of the Israeli company since 2013.

Part of University of Haifa, Carmel-Haifa University Economic Corp. Ltd. operates a university of commercialization and business. The company is based in Haifa, Israel. Elka Nir has been the CEO of the Israeli company since 2013.